Nanox Imaging's subsidiary, Nanox AI, has secured an exclusive three-year reseller agreement with Vertec Scientific to commercialize its HealthOST bone solution in the UK. This deal expands Nanox AI's market reach for its diagnostic software, contingent on Vertec meeting minimum annual license commitments.
Nanox Imaging, through its Nanox AI subsidiary, has entered into a significant reseller agreement with Vertec Scientific for its HealthOST bone solution in the United Kingdom. This grants Vertec exclusive rights to market and resell the product for an initial three-year term, provided they meet minimum annual license commitments. This development is a positive step for Nanox as it expands the commercialization of its AI-powered diagnostic tools into a new, major market. While the immediate financial impact isn't quantified, it represents a long-term opportunity for revenue growth and increased adoption of their technology. Traders should view this as a moderate positive catalyst, indicating progress in their commercial strategy, though the actual revenue generation will depend on Vertec's performance.